---
title: "Lushang Freda Pharmaceutical to Divest Lushang Inzone Commercial Management Subsidiary for 88 Milion Yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/260868081.md"
description: "Lushang Freda Pharmaceutical to Divest Lushang Inzone Commercial Management Subsidiary for 88 Milion Yuan"
datetime: "2025-10-13T09:25:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260868081.md)
  - [en](https://longbridge.com/en/news/260868081.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260868081.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/260868081.md) | [繁體中文](https://longbridge.com/zh-HK/news/260868081.md)


# Lushang Freda Pharmaceutical to Divest Lushang Inzone Commercial Management Subsidiary for 88 Milion Yuan



### Related Stocks

- [Freda (600223.CN)](https://longbridge.com/en/quote/600223.CN.md)

## Related News & Research

- [CSPC Pharmaceutical says emicizumab injection (SYS6053) obtains clinical trial approval in China](https://longbridge.com/en/news/277802565.md)
- [13:50 ETNejvětší farmaceutický veletrh v Asii se v červnu 2026 vrátí do Šanghaje](https://longbridge.com/en/news/277666717.md)
- [Navigating uncertainty and building resilient supply chains: The case for US-based CDMO partnerships](https://longbridge.com/en/news/277756800.md)
- [833K Reasons To Be Bullish On ANI Pharmaceuticals Stock](https://longbridge.com/en/news/277645035.md)
- [12:15 ETPeli BioThermal Announces Strategic Partnership with Polar Group in Brazil](https://longbridge.com/en/news/277501360.md)